Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Crispr Therapeutics Ag (CRSP)

Crispr Therapeutics Ag (CRSP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,875,129
  • Shares Outstanding, K 76,201
  • Annual Sales, $ 720 K
  • Annual Income, $ -348,870 K
  • 60-Month Beta 2.25
  • Price/Sales 13,196.87
  • Price/Cash Flow N/A
  • Price/Book 3.57
Trade CRSP with:

Options Overview

Details
  • Implied Volatility 60.53%
  • Historical Volatility 48.36%
  • IV Percentile 16%
  • IV Rank 20.65%
  • IV High 99.59% on 02/01/21
  • IV Low 50.36% on 09/17/21
  • Put/Call Vol Ratio 1.08
  • Today's Volume 6,308
  • Volume Avg (30-Day) 4,763
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 59,912
  • Open Int (30-Day) 61,025

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -1.68
  • Number of Estimates 9
  • High Estimate -1.32
  • Low Estimate -1.83
  • Prior Year -1.32
  • Growth Rate Est. (year over year) -27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
114.42 +1.79%
on 09/15/21
129.50 -10.06%
on 09/01/21
-0.75 (-0.64%)
since 08/20/21
3-Month
113.34 +2.76%
on 07/27/21
169.76 -31.39%
on 06/30/21
-11.36 (-8.89%)
since 06/18/21
52-Week
79.31 +46.85%
on 10/02/20
220.20 -47.11%
on 01/15/21
+30.57 (+35.59%)
since 09/18/20

Most Recent Stories

More News
A Second Week of Declines as September Continues

A Second Week of Declines as September Continues

SATS : 25.97 (-0.57%)
ROKU : 316.01 (-2.50%)
PXD : 149.36 (-4.90%)
FISV : 107.33 (-1.19%)
TWST : 114.04 (-6.32%)
PACB : 27.99 (-4.93%)
NVTA : 30.83 (-2.25%)
CRSP : 116.47 (-6.46%)
Why CRISPR Therapeutics AG (CRSP) is a Top Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

CRSP : 116.47 (-6.46%)
5 Reasons to Buy Vertex Pharmaceuticals (VRTX) Stock Now

New reimbursement agreements in ex-U.S. markets and label expansions to younger age groups should drive sales of Vertex's (VRTX) cystic fibrosis drug, Trikafta sales higher.

VRTX : 185.67 (-1.40%)
MRNA : 423.33 (-1.56%)
CRSP : 116.47 (-6.46%)
KYMR : 60.49 (-3.91%)
CRISPR Therapeutics AG (CRSP) Stock Moves -0.59%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed at $120.74 in the latest trading session, marking a -0.59% move from the prior day.

CRSP : 116.47 (-6.46%)
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $127.07, marking a +0.56% move from the previous day.

CRSP : 116.47 (-6.46%)
Vertex (VRTX) Inks New Deal for CRISPR Gene-Editing Rights

Vertex (VRTX) collaboration with Arbor will support discovery & development of new treatment options for serious diseases using the latter's CRISPR technology.

VRTX : 185.67 (-1.40%)
MRNA : 423.33 (-1.56%)
CRSP : 116.47 (-6.46%)
KYMR : 60.49 (-3.91%)
Earnings Growth & Price Strength Make CRISPR Therapeutics AG (CRSP) a Stock to Watch

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

CRSP : 116.47 (-6.46%)
Illumina vs. CRISPR: Which Genomics Stock is a Better Choice?

The genomics industry has been the recipient of immense investor attention owing to its crucial role in the genome sequencing of the deadly COVID-19 virus. As the need for gene-based tests is on the rise...

ILMN : 438.00 (-2.02%)
CRSP : 116.47 (-6.46%)
Editas (EDIT) Up More Than 70% in Past 3 Months: Here's Why

Editas' (EDIT) lead candidate, EDIT-101, which employs CRISPR gene editing to treat LCA10, holds potential. The company is also developing EDIT-301 for treating hematologic diseases.

BEAM : 95.31 (-7.39%)
EDIT : 58.20 (-7.91%)
NTLA : 148.36 (-5.68%)
CRSP : 116.47 (-6.46%)
How Are Genomics ETFs Responding to Q2 Earnings?

Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.

BEAM : 95.31 (-7.39%)
EDIT : 58.20 (-7.91%)
PBE : 76.17 (-1.98%)
NTLA : 148.36 (-5.68%)
CRSP : 116.47 (-6.46%)
ARKG : 80.33 (-4.29%)
GNOM : 23.25 (-4.00%)
IDNA : 53.54 (-3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

See More

Key Turning Points

3rd Resistance Point 126.10
2nd Resistance Point 123.73
1st Resistance Point 120.10
Last Price 116.47
1st Support Level 114.10
2nd Support Level 111.73
3rd Support Level 108.10

See More

52-Week High 220.20
Fibonacci 61.8% 166.38
Fibonacci 50% 149.76
Fibonacci 38.2% 133.13
Last Price 116.47
52-Week Low 79.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar